Results 21 to 30 of about 231,111 (314)
Impact of allergen immunotherapy after two years of suspension in patients with asthma
Revista Alergia México, 2016 Background: Immunotherapy has proven to be effective in controlling allergic asthma. However, few studies have evaluated whether the control and reduction of drug treatment persist after treatment ends.
Jorge Sánchez +2 more
doaj +1 more source
Knowledge-map analysis of bladder cancer immunotherapy
Human Vaccines & Immunotherapeutics, 2023 This study aimed to conduct a bibliometric analysis in the field of bladder cancer (BC) immunotherapy, and explore the research trends, hotspots and frontiers from 2000 to 2022.
Zongwei Lv +5 more
doaj +1 more source
Lymphocyte active immunotherapy for unexplained recurrent spontaneous abortion
Bangladesh Journal of Pharmacology, 2018 This study is to evaluate the curative effect of lymphocyte active immune treatment for unexplained recurrent spontaneous abortion. Fourteen randomized controlled trials of 994 subjects were included.
Xian Jiang Wei, Xiao Qin Fang, Ling Tong
doaj +1 more source
Active treatment for food allergy
Allergology International, 2016 Food allergy has grown in rapidly in prevalence, currently affecting 5% of adults and 8% of children. Management strategy is currently limited to 1) food avoidance and 2) carrying and using rescue intramuscular epinephrine/adrenaline and oral ...
Aaron K. Kobernick, A. Wesley Burks
doaj +1 more source
Can Natural Products be Used to Overcome the Limitations of Colorectal Cancer Immunotherapy?
Frontiers in Oncology, 2022 Colorectal cancer (CRC) is a common cancer of the digestive system that endangers human health. Immunotherapy is widely used in the treatment of patients with cancer.
Jiahuan Dong +9 more
doaj +1 more source
Active immunotherapy for Alzheimer's disease [PDF]
The Lancet Neurology, 2012 Alzheimer’s disease is the most common cause of dementia globally, affecting about 36 million people at present and with about 115 million people expected to have the disease by 2050.1 It is one of the most important health care, social, and economic challenges of the 21st century.
openaire +2 more sources
Light-activated nanomaterials for tumor immunotherapy
Frontiers in Chemistry, 2022 Tumor immunotherapy mainly relies on activating the immune system to achieve antitumor treatment. However, the present tumor immunotherapy used in the clinic showed low treatment efficacy with high systematic toxicity. To overcome the shortcomings of traditional drugs for immunotherapy, a series of antitumor immunotherapies based on nanomaterials have ...
Fang Wang +11 more
openaire +3 more sources
Blocking entry of hepatitis B and D viruses to hepatocytes as a novel immunotherapy for treating chronic infections [PDF]
, 2021 Background. Chronic hepatitis B and D virus (HBV/HDV) infections can cause cancer. Current HBV therapy using nucleoside analogues (NAs) is life-long and reduces but does not eliminate the risk of cancer.
Ahlén, G +13 more
core +1 more source
AllergoOncology: High innate IgE levels are decisive for the survival of cancer-bearing mice
World Allergy Organization Journal, 2019 Background: Atopics have a lower risk for malignancies, and IgE targeted to tumors is superior to IgG in fighting cancer. Whether IgE-mediated innate or adaptive immune surveillance can confer protection against tumors remains unclear.
Josef Singer +6 more
doaj +1 more source
Specific Active Immunotherapy for Melanoma
Annals of Surgery, 1979 The most effective immunization historically has been active immunization against a specific disease process. We report here the results of specific active immunization of 719 patients with invasive melanoma. The patients were sequentially immunized with approximately 2.5 × 107 x-irradiated, neuraminidase treated melanoma cells and BCG was used for its
H F, Seigler +5 more
openaire +3 more sources